oa SA Pharmaceutical Journal - New drug focus

Volume 74, Issue 9
  • ISSN : 2221-5875
  • E-ISSN: 2220-1017



Antiretroviral update - Reyataz(R), Truvada(R) and Viread(R)

Several antiretrovirals for the management of HIV-1 infection have recently been registered in South Africa. Since antiretrovirals are not used as monotherapy and since several treatment guidelines are available on the appropriate use of antiretroviral medicines in South Africa, it was decided to discuss three of the recently registered antiretrovirals together and to highlight where they fit into HIV treatment regimens.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error